Share-based Payment Arrangement, Expense of Annovis Bio, Inc. from 30 Sep 2021 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Annovis Bio, Inc. quarterly Share-based Payment Arrangement, Expense in USD history and change rate from 30 Sep 2021 to 30 Sep 2025.
  • Annovis Bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $444,647, a 13% increase year-over-year.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)

Annovis Bio, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $444,647 +$51,567 +13% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $496,618 -$1,099,894 -69% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $499,887 +$135,122 +37% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q3 2024 $393,080 -$239,111 -38% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 $1,596,512 +$25,019 +1.6% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q2
Q1 2024 $364,765 -$1,177,573 -76% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q3 2023 $632,191 -$1,723,820 -73% 01 Jul 2023 30 Sep 2023 10-Q 08 Nov 2024 2024 Q3
Q2 2023 $1,571,493 -$332,268 -17% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2024 Q2
Q1 2023 $1,542,338 -$1,892,606 -55% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024 2024 Q1
Q3 2022 $2,356,011 +$1,570,069 +200% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023 2023 Q3
Q2 2022 $1,903,761 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 $3,434,944 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1
Q3 2021 $785,942 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022 2022 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.